International Journal of Medical and Pharmaceutical Research
2025, Volume-6, Issue 6 : 1288-1293
Original Article
Factors Affecting the Regularity of Follow-Ups in Patients with Schizophrenia Attending a Tertiary Hospital Psychiatry Unit - A Chart Review
 ,
 ,
Received
Nov. 5, 2025
Accepted
Dec. 1, 2025
Published
Dec. 12, 2025
Abstract

Background: Schizophrenia is one of the most disabling chronic mental illnesses. It requires treatment with long-term antipsychotics, at times over one’s lifespan. Among other factors, regular contact with the treating team can improve adherence to medication, thus defining the course and outcome of the illness. Adherence is in turn influenced by several key factors - gender, educational status, marital status, family support, type of schizophrenia, medication, its side effects etc.

Aim: To enumerate the factors influencing the regularity of contact in individuals with schizophrenia and the treating team.

Methods: Case-records of patients diagnosed with schizophrenia who received inpatient care at a tertiary care hospital over two years were reviewed. Socio-demographic data, illness-related factors and follow-up visit details noted.

Results: 109 case-records were reviewed of whom 42 had no further consultation following discharge. Of the remaining, a majority were females (78.12%) urban dwellers (75.8%) educated up to secondary levels (71.74%), married (65.85%) from nuclear families (69.23%). Most of them had a shorter duration of illness (70.37%), predominantly paranoid subtype (68.9%), were prescribed oral atypical antipsychotics, in remission/showed an improving trend in symptomatology (75%) during their last consultation. There were no statistically significant differences in socio-demographic profile and illness characteristics in both groups.

Conclusion: Regularity of patient follow-up cannot be predicted based on sociodemographic profile, subtype, phenomenology or route of medication administration. It thus becomes the responsibility of the treating team to counsel patient and caregivers about the nature of illness, the importance of regular follow-up and treatment adherence at the very first point of contact, to ensure a favourable course and outcome.

Keywords
INTRODUCTION

Schizophrenia is a severe form of mental illness affecting about 24 million people globally. Although the incidence is low, the prevalence of schizophrenia is high as it is a long-term chronic illness. [1] Effective management of schizophrenia requires continuous long-term treatment to keep symptoms under control and to prevent relapse. [2][3] Regular contact with the treating team ensures medication adherence and probably a favourable outcome.

 

Non-attendance at scheduled appointments is a prevalent issue in health care. Each year countless patients in various healthcare settings do not attend scheduled appointments. The rate of missed appointments varies between 5% and 30%, across different countries. They interrupt continuity of care, delay necessary treatments, and significantly affect clinical outcomes.[4] Missed appointments can cause non adherence to medication. Non-adherence to prescribed drug treatments has been recognized as a problem worldwide and may be the most challenging aspect of treating patients with schizophrenia. Non-adherence, encountered more often during maintenance treatment, adversely affects the prognosis, as it exacerbates symptoms in the early period of the disease.[5]Early follow-up after discharge, within 7 days, reduces risk of relapse and risk of suicide.[6] Those who do not comply with this are more likely to be hospitalised.[7] Non-adherence is associated with psychiatric readmission, is the most common stressor for recurrence, and results in the likelihood of poor health status.[8][9]

 

Consistently reported factors influencing attendance to follow-up include insight, beliefs about treatment, medication side effects, and treatment efficacy. Apart from these other factors affecting non-attendance at scheduled appointments are gender, personality, family support, other demographic variables, age at onset, illness duration and service availability.[10] Although research has improved our knowledge, adherence rates do not seem to have changed in the last 4 decades.[11]

 

Studies aiming at recognising the factors responsible for irregular visits to the treating centre/ non-adherence, are few in the Indian context. The current study aims to look at these factors retrospectively, to gain insight into the same, and plan strategies for effective intervention to ensure regular follow-ups with the treating team and thereby adherence.

 

METHODOLOGY

Study Design

Case records of patients diagnosed with schizophrenia according to ICD 10 treated at the Department of Psychiatry at a tertiary care centre over a two-year period, were included in the study.

 

Socio demographic details, illness related data (subtype of schizophrenia, duration of illness), medication used (oral or injectable antipsychotics), occurrence of drug induced side effects, regularity in visiting the treating hospital,and clinical status during the last follow up were noted. Treatment dropouts were considered as those who did not return to the hospital following discharge. 3 or more visits per year were noted as regular follow up.

 

DATA ANALYSIS

The statistical software namely Statistical Package for the Social Sciences (SPSS) version 18.0 and R environment ver. 3.2.2 (SPSS inc, Chicago, United States of America) were used for the analysis of the data and Microsoft word and Excel have been used to generate graphs, tables, etc. Descriptive and inferential statistical analyses have been carried out in the present study. Results on continuous measurements are presented on mean ± standard deviation (min-max) and results on categorical measurements are presented in number (%). Significance is assessed at 5% level of significance. Student's t-test (two-tailed, independent) has been used to find the significance of study parameters on continuous scale between two groups (intergroup analysis) on metric parameters. Chi-square/Fisher's Exact test has been used to find the significance of study parameters on categorical scale between two or more groups, nonparametric setting for qualitative data analysis. 

 

RESULTS

 

Figure 1: Selection of Study participants

 

Table 1: Socio-demographic and illness related details of the included patients are as follows(n=67)

 

N (%)

 

(mean +/- SD)

Gender

 

Age

34.67 +/- 10.3

Male

35(52.23%)

Duration of illness

6.55 +/- 8.73

Female 

32(47.76%)

   

Educational status

 

   

<SSLC

21(31.34%)

   

>SSLC  

46(68.66%)

   

Marital status

 

   

 Single

20(29.85%)

   

Married

41(61.19%)

   

Widowed

1(1.49%)

   

Separated

2(2.98%)

   

Divorced 

2(2.98%)

   

Residential status

 

   

 Urban

35(52.23%)

   

 Rural

32(47.76%)

   

Type of family

 

   

Nuclear

54(80.6%)

   

Joint/Extended

13(19.4%)

   

Type of schizophrenia

 

   

Paranoid

61(91.04%)

   

Simple

5(7.4%)

   

Undifferentiated

1(1.5%)

   

Predominant symptoms

 

   

Positive

61(91.04%)

   

Negative

6(8.9%)

   

 

Older age group, female, educated up to or beyond class 10, married, living in urban area, belonging to nuclear family, with paranoid subtype of schizophrenia, ill for less than 10 years, with predominant positive symptoms tended to have a regular follow up. They tended to be on injectable antipsychotics and asymptomatic at the last follow up, (Table 1)

 

Table 2: Factors affecting the regularity of follow-up

Factors

Regular Follow- up

(i.e>3/y) n=45

Irregular follow- up

(i.e<3/y) n=22

Chi-square analysis

P value

Age: 11-40y

         41-80y

33(63.46%)

12(80%)

19(36.64)

3(20%)

0.2489

Sex:  Male

         Female

20(57.14%)

25(78.12%)

15(42.86%)

7(21.87%)

0.07553

Education: <SSLC

                   >SSLC

12(60%)

34(72.34%)

8(40%)

13(27.65%)

0.338

Marital status: Single

                        Married

17(68%)

28(66.66%)

8(32%)

14(33.33%)

0.9195

Residential status: Urban

                              Rural

27(77.14%)

18(56.25%)

8(22.86%)

14(43.75%)

0.077

Family type: Nuclear

                      Joint

38(69.09%)

7(58.33%)

17(30.90%)

5(41.67%)

0.489

Type of schizophrenia

Paranoid

Simple

 

42(68.9%)

3(50%)

 

19(31.1%)

3(50%)

 

0.389

Duration of illness

0-10y

>10y

 

38(70.37%)

7(53.85%)

 

16(29.63%)

6(46.15%)

 

0.28

Predominant symptoms

Positive

Negative

 

42(68.86%)

3(50%)

 

19(31.15%)

3(50%)

 

0.389

Antipsychotic agents used

Risperidone

Olanzapine

Amisulpride

 

19(57.58%)

11(73.33%)

6(85.71%)

 

14(42.42%)

4(26.67%)

1(14.29%)

 

 

-

Injectable antipsychotics

9(60%)

6(40%)

-

Clinical status at the last follow-up

Asymptomatic

Symptomatic

 

30(75%)

15(55.56%)

 

10(25%)

12(44.44%)

 

0.108

 

None of the above parameters were however statistically significant.

 

Table 3: Socio-demographic and illness-related details of the treatment drop-out group (N=42)

Factors

No follow-up (% of total treatment drop-out)

Age 11-40y

        41-80y

34(80.95) 33/19=52 (77.6%)

8(19.05) 12/3=15 (22.4%)

Sex Male

       Female

24(57.14) 20/15 (52.2%)

18(42.86) 25/7 (47.8%)

Education <SSLC

                 >SSLC

12(28.57)12/8 (30%)

30(71.43) 34/13 (70%)

Marital status Single

                      Married

18(42.86) 17/8 (37.3%)

24(57.14) 28/14 (62.7%)

Resident Urban

               Rural

24(57.14)27/8 (52.2%)

18(42.86) 18/14 (47.8%)

Family type Nuclear

                     Joint

28(66.67) 38/17 (82%)

14(33.33) 7/5 (18%)

Type of schizophrenia

Paranoid

Simple

Paranoid

36(85.71) 42/19 (91%)

6(14.29) 3/5 (9%)

Duration of illness <10y

                               >10y

38(90.48) 38/16 (83.5%)

4(9.52) 7/6 (16.5%)

Predominant Positive

                     Negative

37(88.09) 42/19 (91%)

5(11.9) 3/5 (9%)

 

The socio demographic profile of the 42 patients considered treatment dropouts were almost similar to those who maintained frequent follow up, and were not distinctly different.

 

DISCUSSION

Non-attendance at scheduled appointments is a prevalent issue in healthcare. Each year countless patients in various healthcare settings do not attend scheduled appointments. The rate of missed appointments varies between 5% and 30%, across different countries, while in some up to 50%.[4][12][13]Missed appointments can cause non-adherence.

 

Several factors influence the long-term course and outcome of schizophrenia, with missed appointments contributing to non-adherence being significant. Non-adherence is associated with psychiatric readmission, is the most common stressor for recurrence  and results in the likelihood of poor health status.[8][9] A recent review reported that non-adherence and partial adherence can set in motion a ‘downward spiral’ of events resulting in inconsistent symptom control, relapse, rehospitalization, which in turn can lead to long-term functional disabilities, loss of autonomy, education or employment possibilities, homelessness, a likelihood of dropping out of care completely and even suicide.[14]

 

In the current study, it was found that the older age group, female, educated up to or beyond class 10, married, living in an urban area, belonging to a nuclear family, with the paranoid subtype of schizophrenia, ill for less than 10 years, having predominant positive symptoms tended to have a regular follow up. They also tended to be on injectable antipsychotics and asymptomatic at the last follow-up.

 

None of the above parameters were however statistically significant.

 

Age:

Research has varied findings regarding the influence of age on the regularity of follow-up. While some have found no significant correlation between age and missed appointments, some have found that older patients were more likely to miss appointments while others found that younger patients were more likely to do the same.[4][9][16]

 

Older adults may have a poor understanding of their condition and fail to understand the need for continuous care. Certain older individuals may need to be accompanied for their hospital visits, and this may not always be possible. Difficulty in transportation or the presence of multiple health issues may also play a role.

 

The better-preserved younger individuals with schizophrenia on the other hand may have difficulty getting away from a job they need to keep. Those with a more severe form of the illness would need adults to accompany them, who may themselves be working. Hence the regularity of keeping appointments may not be specific to the age of the patient.

 

Gender:

Men were more likely to miss first appointments after discharge, while women had a higher likelihood of follow-up in the seven days after discharge. There is a likelihood that male schizophrenics are uncooperative for regular follow-up and the family has a difficult task bringing them.[4][6][8]

 

Education:

Individuals with schizophrenia who had a higher level of education were less prone to miss appointments. The likelihood of missing an appointment increases three-fold among patients with lower levels of education.[4] Lack of formal education increases the risk of missing an appointment by 30% and the risk increases by 60%when compared to individuals with a university degree.[15] Education levels were however not significantly related to missed appointments in some research.[4] Higher levels of education in an individual facilitate a more comprehensive understanding of health, ensuring that they are committed to keeping appointments.

 

Marital status:

Married individuals were less likely to miss appointments, suggesting that support from a spouse, financial stability and a heightened sense of responsibility could contribute. Single, divorced, widowed or living alone had a higher tendency to miss appointments.[4][7]

 

Location:

Studies report that patients admitted at a metropolitan city facility had a higher follow-up. Those admitted to rural hospitals had 26% lower odds of receiving outpatient care within seven days of discharge. Those living in urban locations have easier access to health care, and can sustain outpatient attendance.[6]

 

Socioeconomic status:

Missed appointments were common among patients from a lower socio-economic status.[4][15] Financial status of the patient probably influences regularity of follow-up as the expenses incurred during hospital visits are hard to bear along with the cost of medication and absenteeism from work for those who are employed.

 

Severity of illness

In a hospital-based research study the prevalence of missed first appointments was 31% and those who had higher BPRS scores were associated with missing the appointment. The reasons stated were forgetting the appointment, and patient’s refusal to come to the clinic, probably contributed to by the presence of active psychotic features and absent insight.[16][17][18]

 

Some other factors have also been found to play a role in missed appointments such as being on typical antipsychotics, comorbid substance abuse, and discharge against medical advice.[6] The side effects of typical antipsychotics, and craving the substance of dependence probably favour the ‘no show’ on appointments.

 

Regularity of follow-up influenced relapses in patients with schizophrenia.[19] Early out-patient follow up, within seven days of discharge has been found to be the core component to reduce relapse and suicide risk.[6] Missed appointments significantly affect clinical outcomes, interrupt continuity, and delay necessary treatments.[4] Those who did not comply with the first follow-up visit after discharge were more likely to be re-hospitalized.[7]

 

In the current study, it was found that older age group, female, educated up to or beyond class 10, married, living in urban area, belonging to nuclear family, with paranoid subtype of schizophrenia, ill for less than 10 years, with predominant positive symptoms tended to have a regular follow up. They tended to be on injectable antipsychotics and asymptomatic at the last follow-up. Although some associations are present, none of these factors are of statistical significance, and hence it is not possible to conclude that any of them alone or in combination are associated with failure to attend the hospital, and subsequently of non-adherence of medications.

 

CONCLUSIONS

It is difficult to segregate patients into those who are likely to have regular/irregular follow-up based on sociodemographic profile, subtype, phenomenology (positive vs negative symptoms), or route of medication administration. Trends in these findings have not changed in the past few decades. It is possible that the input of the treating team, even at the level of a tertiary hospital, failed to lay stress upon factors affecting the course and outcome of the disorder, and the importance of treatment adherence and regular hospital visits. However, it is also possible that those who never visited the hospital again had a benign course of illness and remained asymptomatic after the index episode.

 

With the findings of the current study and available literature, it would be safe to conclude that for all individuals with schizophrenia, interventions addressing appointment attendance are best dealt with at the very first contact with the treating team. Significant caregivers would hence have to be counselled about the nature of the illness, the need for regular follow-up, the need for treatment adherence, and the importance of all these factors in the long-term course and outcome of the illness.

 

REFERENCES

  1. World Health Organization. Schizophrenia [Internet]. Geneva: World Health Organization; 2022 Jan 10 [cited 2025 Jul 1]. Available from: https://www.who.int/news-room/fact-sheets/detail/schizophrenia
  2. Peuskens J, Gillain B, De Graeve D, Van Vleymen B, Albert A. Belgian Schizophrenia Outcome Survey-results of a 2-year naturalistic study in patients stabilised on monotherapy with olanzapine, risperidone or haloperidol. Eur Psychiatry 2009;24:154-163.
  3. Lehman AF, Buchanan RW, Dickerson FB, Dixon LB, Goldberg R, Green-Paden L, Kreyenbuhl J. Evidence-based treatment for schizophrenia. Psychiatr Clin North Am. 2003 Dec;26(4):939-54.
  4. Alturbag M. Factors and reasons associated with appointment non-attendance in hospitals: a narrative review. 2024 19;16(4).
  5. Eskin M. Rural population’s opinions about the causes of mental illness, modern psychiatric help-sources and traditional healers in Turkey. Int J Soc Psychiatry 1989; 35:324-328.
  6. Che SE, Kim KH. Factors Associated With Receiving Early Post-Discharge Follow-up Care in Patients With Schizophrenia. Journal of Korean Medical Science. 2024 25;40(3).
  7. Cheng KD, Huang CJ, Tsang HY, Lin CH. Factors related to missed first appointments after discharge among patients with schizophrenia in Taiwan. Journal of the Formosan Medical Association. 2014 ;113(7):436-41.
  8. Kal MJ, Kim WH, Cho JW, Kim JH, Lee JS, Bae JN, Kim CE. Factors affecting recurrence in patients with schizophrenia received more than 10 years of treatment. Korean Journal of Schizophrenia Research. 2015;18(2):66-72.
  9. Smithnaraseth A, Seeherunwong A, Panitrat R, Tipayamongkholgul M. Hospital and patient factors influencing the health status among patients with schizophrenia, thirty days after hospital discharge: multi-level analysis. BMC psychiatry. 2020;20:1-3.
  10. Lacro JP, Dunn LB, Dolder CR, Leckband SG, Jeste DV. Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: A comprehensive review of recent literature. J Clin Psychiat 2002;63:892–909.
  11. Renton CA, Affleck FW, Carstairs GM, Forrest AD. A follow-up of schizophrenic patients in Edinburgh. Acta Psychiat Scand. 1963;39:548–600.
  12. Thara. S.Rajkumar. a study of sample attrition in follow up of schizophrenia. Indian Journal of Psychiatry.1990 ;32(3),217-222.
  13. Kay SR. Lindenmeyer J. Outcome predictors in acute schizophrenia: prospective significance of background and clinical dimensions. J Nerv Ment Dis. 1987;175:152–160.
  14. Llorca P. Partial compliance in schizophrenia and the impact on patient outcomes. Psychiatry Res. 2008;161: 235–247.
  15. Dantas LF, Fleck JL, Oliveira FL, Hamacher S. No-shows in appointment scheduling–a systematic literature review. Health Policy. 2018;122(4):412-21.
  16. Barnett BS, Kusunzi V, Magola L, Borba CP, Udedi M, Kulisewa K, Hosseinipour MC. Risk factors for readmission among a cohort of psychiatric inpatients in Lilongwe, Malawi. International journal of psychiatry in clinical practice. 2020 ;24(1):25-30.
  17. Daniels K, Loganathan M, Wilson R, Kasckow J. Appointment attendance in patients with schizophrenia. Clinical Practice. 2014;11(4):467.
  18. Thomas FI, Olotu SO, Omoaregba JO. Prevalence, factors and reasons associated with missed first appointments among out-patients with schizophrenia at the Federal Neuro-Psychiatric Hospital, Benin City. BJPsych Open. 2018 4(2):49-54.
  19. Rajkumar S, Thara R. Factors affecting relapse in schizophrenia. Schizophrenia Research. 1989 ;2(4-5):403-9.
Recommended Articles
Original Article Open Access
Assessment of lumbar lordosis and pelvic parameters in chronic low back pain patients
2025, Volume-6, Issue 6 : 1311-1317
Original Article Open Access
COMPARATIVE STUDY OF DYNAMIC HIP SCREW VS. PROXIMAL FEMORAL NAIL IN INTERTROCHANTERIC FRACTURES
2025, Volume-6, Issue 6 : 1318-1323
Original Article Open Access
A Randomized Controlled Trial Comparing Three Different Doses of Dexmedetomidine as an Effective Modality for Prevention of Post-Spinal Anaesthesia Shivering at Tertiary Care Centre
2025, Volume-6, Issue 6 : 1270-1276
Original Article Open Access
Morphometric Analysis of the Hard Palate and Its Surgical Significance
2025, Volume-6, Issue 6 : 1300-1302
International Journal of Medical and Pharmaceutical Research journal thumbnail
Volume-6, Issue 6
Citations
14 Views
25 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
Creative Commons Attribution License Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
facebook twitter linkedin mendeley research-gate
© Copyright | International Journal of Medical and Pharmaceutical Research | All Rights Reserved